What Causes IBS? The Gut–Brain Mechanisms, Triggers, and Why There's No Single Cause
IBS has no single cause — it's a disorder of gut–brain interaction.

Short Answer
IBS does not have one single cause. It is best understood as a disorder of gut–brain interaction — the newer, less stigmatizing name for what used to be grouped under “functional” gastrointestinal disorders. In plain language, IBS happens when the gut and nervous system stop coordinating smoothly: ordinary digestion can be read as pain, the bowel may move too fast or too slowly, and the gut can become more sensitive even when routine tests do not show visible damage. (my.clevelandclinic.org)
That does not mean IBS is “all in your head.” Your gut has its own nervous system, immune signals, microbes, hormones, stretch sensors, and pain pathways, and all of them talk to the brain in both directions. Research points to several contributors that often stack together: altered brain–gut signaling, visceral hypersensitivity — a lower pain threshold in the gut — changes in gut motility, shifts in the gut microbiome, small intestinal bacterial overgrowth in some people, food sensitivities, stress-system and autonomic nervous system changes, and, for some, an earlier episode of gastrointestinal infection known as post-infectious IBS. (niddk.nih.gov)
A useful way to think about IBS is: mechanisms are not the same as triggers. The mechanism is the body pattern that makes the gut easier to set off — sensitive nerves, disrupted gut–brain signaling, altered motility, microbiome changes, immune or barrier changes after infection. A trigger is what lights that pattern up on a given day: a meal, poor sleep, stress, a menstrual phase, alcohol, certain carbohydrates, or a recent stomach bug. Diet usually does not cause IBS by itself, but specific foods commonly trigger symptoms because the gut is already tuned to react more strongly. (health.clevelandclinic.org)
That is why two people can both have IBS and feel completely different. One person’s IBS may be dominated by diarrhea after an infection. Another person may have constipation, bloating, and pain that flare during stress. Another may mainly notice food-related episodes. The shared thread is not one broken organ; it is a changed communication system between the gut, the brain, the immune environment, and the autonomic nervous system. Because those pieces combine differently, there is no single IBS test and no single root cause to “find.” Clinicians usually diagnose IBS from a symptom pattern over time while checking for signs that point to another condition. (niddk.nih.gov)
What our own data shows.
Among 612 Welltory users who self-report IBS, compared with 3,533 users without an IBS self-report (anonymized, aggregated app data; snapshot 2026-07-06), the clearest gap is not in the hardware readings — it is in how people feel. Brain fog showed up on daily check-ins for 55% of the self-report-IBS group versus 21% of the comparison group (Cohen's d ≈ 0.78), and this gap held up like-for-like when we compared people with a similar overall number of reported conditions — so it tracks the IBS flag itself, not simply "being sicker in general." End-of-day physiological pressure was also modestly higher (median 51.6 vs 46.7; d ≈ 0.21). Other differences — a slightly higher resting heart rate (64.9 vs 62.4 bpm), fewer daily steps (6,622 vs 7,636), and more reported brain fog on the broader survey (37% vs 23%) — are real gaps, but they largely reflect the cluster of co-occurring conditions IBS travels with, not IBS alone. This is self-reported, not a clinical diagnosis, and no wearable can diagnose IBS or tell you why it happened.
What causes IBS — at a glance
IBS usually isn’t caused by one thing you ate, one stressful week, or one “bad” test result. It’s better understood as a disorder of gut–brain interaction: your gut, nerves, immune signals, microbes, and stress-response system can start amplifying each other. That’s why one person’s IBS begins after food poisoning, another’s after a high-stress period, and another’s seems to run in the family. The useful split is: mechanisms are what keep symptoms happening in the body; triggers are what set off flares or new-onset IBS in a susceptible person; predispositions are the background factors that make the system easier to tip. (niddk.nih.gov)
| Contributor | What it is | How it's linked to IBS | Class |
|---|---|---|---|
| Altered brain–gut interaction | The two-way signaling loop between your gut, enteric nerves, autonomic nervous system, immune signaling, and brain becomes poorly coordinated. | This is the core IBS frame: NIDDK describes IBS as a problem of brain–gut interaction, and Cleveland Clinic classifies IBS among disorders of gut–brain interaction rather than as “all in your head.” When the loop is overreactive, normal digestion can feel urgent, painful, bloated, or unpredictable. (niddk.nih.gov) | Core mechanism |
| Visceral hypersensitivity | A lower pain threshold inside the gut — the “volume knob” on internal sensation is turned up. | Gas, stool, stretching, or normal movement can be registered as pain or pressure. NIDDK notes that some people with IBS feel pain from a normal amount of gas or stool, and Cleveland Clinic describes people with IBS as tending to have extra-sensitive GI nerves and lower pain tolerance. (niddk.nih.gov) | Core mechanism |
| Altered gut motility | Gut contractions move too fast, too slow, or in a poorly coordinated pattern. | Faster transit can lean toward diarrhea; slower transit can lean toward constipation. Mayo Clinic describes stronger, longer contractions as linked with gas, bloating, and diarrhea, while weaker contractions can slow passage and lead to harder stools. NIDDK also links brain–gut problems with food moving too slowly or too quickly through the digestive tract. (mayoclinic.org) | Mechanism behind bowel-habit subtype |
| Gut microbiome changes — dysbiosis | Shifts in gut bacteria, fungi, viruses, and their metabolites, including signaling molecules such as serotonin and short-chain fatty acids. | Microbiome changes are associated with IBS symptoms and may affect the gut–brain–microbiome axis. A meta-analysis found higher blood serotonin in people with IBS versus healthy controls, while fecal short-chain fatty acids were not consistently different overall — a reminder that dysbiosis is a pathway, not a single simple lab finding. (mayoclinic.org) | Mechanism / associated pathway |
| Prior GI infection — post-infectious IBS | IBS that starts after gastroenteritis from bacteria, viruses, or parasites; SARS-CoV-2 is now discussed in the same post-infectious frame. | A classic meta-analysis found a median IBS prevalence of 9.8% after infectious gastroenteritis versus 1.2% in controls, with pooled odds about sevenfold higher after infection. For post-COVID IBS, a 2026 review reports that about 7.2% of people develop IBS after SARS-CoV-2 infection, with 2.6-fold higher odds than non-infected controls; proposed mechanisms include inflammation, barrier changes, dysbiosis, altered serotonin signaling, and psychosocial stress along the gut–brain axis. (pubmed.ncbi.nlm.nih.gov) | Trigger for new-onset IBS |
| Stress & the autonomic nervous system | The fight-or-flight / rest-and-digest balance that tunes gut movement, secretion, sensitivity, and inflammation. | Stress doesn’t mean IBS is imaginary. It means the same nervous system that changes your heart rate and breathing also talks to your gut. Mayo Clinic notes that stress can make IBS symptoms worse, and HRV research shows an autonomic signal: a systematic review/meta-analysis found evidence of lower RMSSD and high-frequency HRV in IBS/IBD compared with healthy controls, while a wearable-based DGBI meta-analysis found reduced RMSSD and pNN50, suggesting lower vagal tone. HRV is a body signal, not an IBS diagnostic test. (mayoclinic.org) | Modulator / measurable physiology signal |
| Early-life / adverse experiences | Early stress, adversity, abuse, or difficult life events that shape stress-response and pain-processing systems. | This is a predisposing factor in a subset, not a moral explanation and not true for everyone with IBS. NIDDK lists stressful or difficult early-life events among problems more common in people with IBS, and Mayo Clinic notes that people exposed to stressful events, especially in childhood, tend to have more IBS symptoms. (niddk.nih.gov) | Predisposition |
| Diet triggers — not a root cause | FODMAPs, large or fatty meals, caffeine, alcohol, carbonation, and individual intolerances can provoke symptoms in a sensitized gut. | Food usually acts more like a match than the whole fire. Mayo Clinic notes that true food allergy rarely causes IBS, but many people have worse symptoms after certain foods or drinks. NIDDK lists the low-FODMAP diet as a possible symptom-management approach, and meta-analyses of trials show symptom benefit: one found global symptom improvement with low-FODMAP diets versus controls (RR 1.54), and another found a moderate-to-large reduction in IBS severity (SMD −0.66). (mayoclinic.org) | Trigger / management lever, not a cause |
Mechanism vs. trigger vs. predisposition — how the pieces fit
IBS makes more sense when you stop looking for one “cause” and separate the stack: what makes your system vulnerable, what sets symptoms off, and what your body is doing to produce pain, bloating, diarrhea, constipation, or both. NIDDK describes IBS as a problem of brain–gut interaction, where different people can have different contributing factors — including gut infections, food sensitivities, early-life stress, mental health conditions, SIBO, and genes — rather than one single origin story. (niddk.nih.gov)
| Layer | What it means for IBS | Example |
|---|---|---|
| Predisposition | This is the baseline vulnerability you carry before a flare ever happens. It can come from genes, early-life stress, the way your nervous system processes threat and sensation, or a history of anxiety, depression, PTSD, or other stress-related conditions. It is not a character flaw, and it does not mean IBS is “all in your head.” (niddk.nih.gov) | You may have a gut–brain system that is easier to sensitize, so normal digestion is more likely to be felt as pressure, urgency, cramping, or pain. |
| Trigger | This is the event that starts IBS or wakes it up again. A trigger can be a gut infection, a stressful period, or a food pattern that your gut does not tolerate well. Triggers matter, but they are not always the whole cause — the same meal or stressful week may barely affect one person and flatten another. (mayoclinic.org) | After gastroenteritis, your bowel habits change and never fully return to baseline; or during a high-stress month, your usual “safe” foods suddenly provoke cramps and urgency. |
| Mechanism | This is the body process that turns vulnerability and triggers into symptoms. In IBS, the main mechanism is altered brain–gut signaling: the gut muscles may move too fast or too slowly, the nerves may become extra sensitive to normal gas or stool, and the brain may amplify those signals into pain or urgency. (pubmed.ncbi.nlm.nih.gov) | A normal amount of gas can feel painful, a normal bowel stretch can feel urgent, and stress can push the gut toward diarrhea, constipation, spasms, or bloating. |
So a cleaner sentence is: IBS is usually not caused by one thing. It often happens when a predisposed gut–brain system meets a trigger, and symptoms persist because the signaling, sensitivity, and motility loops stay dysregulated.
The core idea: IBS is a disorder of gut–brain interaction
For years, IBS was described as a “functional” disorder: your symptoms were real, but routine tests often did not show ulcers, tumors, inflammation, or another visible structural injury. The modern framing is clearer and less dismissive. IBS sits inside a group now called disorders of gut–brain interaction (DGBI) — conditions where the digestive system and nervous system are sending, receiving, or amplifying signals in a way that changes how your gut feels and moves. That can mean pain from normal stretching, diarrhea when motility speeds up, constipation when it slows down, or bloating that feels out of proportion to what a scan or scope can “see.” It is not a euphemism for “it’s in your head.” It is a physiological communication problem between two organ systems. (my.clevelandclinic.org)
A 2026 PubMed-indexed review captures why IBS rarely has one clean cause: the biology is layered, not linear. (pubmed.ncbi.nlm.nih.gov)
"Its pathogenesis involves the interaction of multiple factors, including abnormalities of the brain-gut axis, intestinal microbiota dysbiosis, and visceral hypersensitivity."
That single sentence is the backbone of this whole article. IBS can involve altered gut movement, increased nerve sensitivity, changes in the microbiome, immune or barrier changes after infection, stress-system activation, early-life vulnerability, and genetics — but the mix is different from person to person. That is why one person’s IBS starts after food poisoning, another’s flares during stress, and another’s tracks with constipation, gas, or hormone shifts. It is also why a colonoscopy, stool test, or blood test may be useful to rule out other conditions but still not “show” IBS itself. In most cases, clinicians diagnose IBS by symptom pattern and use tests mainly to check for problems that can mimic it. (niddk.nih.gov)
A newer perspective goes one step deeper. Instead of treating “visceral hypersensitivity” as only a bottom-up problem — oversensitive nerves in the gut shouting too loudly — it also asks how the brain predicts, filters, and interprets incoming body signals. In plain English: your gut may send a signal, but your nervous system helps decide how threatening, painful, urgent, or ignorable that signal feels. Research on DGBI increasingly describes symptom generation as a brain-and-gut process involving visceral nociception, central processing, motility, microbiome, immune function, and psychological state together. (pubmed.ncbi.nlm.nih.gov)
"Traditional bottom-up models of visceral hypersensitivity fail to explain the profound subjective-objective symptom mismatches observed in clinical practice."
That “mismatch” is not proof that symptoms are exaggerated. It is exactly what you would expect when the problem lives in signaling and processing rather than visible tissue damage. A normal amount of gas can hurt. A normal bowel movement can feel incomplete. A gut that looks structurally healthy can still be running with a nervous system that is too reactive, poorly regulated, or stuck in a threat-detection loop. IBS symptoms are real, bodily, and measurable in their effects on daily life — even when the scan looks normal. (my.clevelandclinic.org)
Visceral hypersensitivity and abnormal motility
Two mechanisms sit at the center of everyday IBS symptoms: visceral hypersensitivity and altered motility. Visceral hypersensitivity means your gut’s alarm system is turned up. A normal amount of gas, stool, stretching, or pressure after a meal can be read by the nerves in the gut as “too much,” so your brain receives pain, cramping, urgency, or bloating signals from sensations that might not bother someone else. This does not mean the pain is imagined. It means the sensory pathway between the gut and brain has become easier to trigger. NIDDK describes this pattern directly: in some people with IBS, normal amounts of gas or stool can be painful, and food may move too slowly or too quickly through the digestive tract. (niddk.nih.gov)
"the role of visceral hypersensitivity, altered brain-gut communication, and luminal factors such as gas and distension"
Altered motility is the movement side of the same gut–brain problem. Your intestines are muscular tubes; they move food, fluid, and stool by coordinated contractions. When those contractions speed up, there is less time to absorb water, so symptoms lean toward loose stool, urgency, and IBS-D. When movement slows down, stool sits longer, dries out, and symptoms lean toward constipation, straining, and IBS-C. If the pattern swings both ways, it can look like IBS-M. Cleveland Clinic describes IBS as a disorder of gut–brain interaction in which dysmotility and extra-sensitive gut nerves can both contribute to cramping, pain, diarrhea, constipation, and discomfort. (my.clevelandclinic.org)
These mechanisms also help explain why IBS can feel inconsistent. The same meal may be fine one week and painful the next because the gut is not reacting to food alone. It is reacting to food plus stretch, gas handling, immune signals, microbiome activity, stress hormones, sleep debt, menstrual-cycle shifts, and the current sensitivity of the nervous system. In other words, the volume knob changes. A review of IBS pain mechanisms describes abdominal pain as multifactorial, involving visceral hypersensitivity, peripheral and central sensitization, altered microbiota, abnormal motility, and impaired gas handling. (pmc.ncbi.nlm.nih.gov)
So visceral hypersensitivity and altered motility are best understood as symptom-sustaining mechanisms, not single root causes. They sit downstream of disrupted gut–brain signaling and are shaped by the microbiome, stress physiology, infection history, diet, and other triggers discussed below. That distinction matters: IBS is not “just sensitive feelings,” and it is not simply “bad digestion.” It is a real change in how the gut senses, moves, and communicates with the brain.
The gut microbiome (dysbiosis) and serotonin
A large share of IBS research now centers on the gut microbiome — the community of bacteria, fungi, viruses, and other microbes living in the intestine. Not because IBS is “an infection” or because one bad microbe explains everything. The point is more subtle: your microbes help break down food, make metabolites, train immune cells, shape the gut barrier, and send chemical signals to nerves. When that ecosystem is shifted — dysbiosis — the gut may become more reactive: more fermentation and gas, faster or slower transit, and a lower threshold for pain.
"Microbial dysbiosis has been implicated in visceral pain and persistent alterations in gut function that occur following inflammation."
Human studies support the association, but they also show why a microbiome test cannot “diagnose” IBS. In a systematic review and meta-analysis of 23 case-control stool studies with 1,340 participants, IBS was associated with lower fecal Lactobacillus and Bifidobacterium, higher Escherichia coli, and marginally higher Enterobacter compared with healthy controls. The reported mean differences were −0.57 log10 CFU/g for Lactobacillus, −1.04 log10 CFU/g for Bifidobacterium, +0.60 log10 CFU/g for E. coli, and +0.74 log10 CFU/g for Enterobacter; most comparisons had substantial heterogeneity, with I² above 75%. In plain English: there are recurring microbial shifts in IBS, but not one universal “IBS microbiome signature.” (pubmed.ncbi.nlm.nih.gov)
One concrete bridge between microbes and symptoms is serotonin — 5-HT. Serotonin is not only a brain chemical. About 95% of the body’s serotonin is produced in the intestine, largely by enterochromaffin cells, and it helps regulate gut motility, secretion, inflammation, and sensation. (pubmed.ncbi.nlm.nih.gov) Microbes can influence that system: experimental work shows that indigenous bacteria from mouse and human microbiota can promote serotonin biosynthesis in colonic enterochromaffin cells, with downstream effects on gut motility and platelet function. (pubmed.ncbi.nlm.nih.gov) That matters for IBS because motility and sensation are exactly the systems that feel “off” when bowel habits swing and normal amounts of gas or stool feel painful.
Broader reviews describe how everyday factors reshape the microbiome and, through it, gut–brain communication:
"Diet, stress, antibiotics, and environment significantly alter gut microbiota composition"
This is why food poisoning, antibiotics, stress, diet changes, and small intestinal bacterial overgrowth are not random footnotes in IBS. They can push the microbial ecosystem, and the ecosystem can push back through metabolites, immune tone, barrier function, serotonin signaling, and gut nerves. NIDDK also lists bacterial infections, SIBO, and food sensitivities among problems that are more common in people with IBS, while emphasizing that experts think different combinations of problems lead to IBS in different people. (niddk.nih.gov)
Frame this honestly: dysbiosis is strongly associated with IBS and is a plausible contributor, especially through gut–brain, immune, motility, and serotonin pathways. But the field has not established that any single microbial pattern causes IBS in humans. If your symptoms flare after antibiotics, food poisoning, major stress, or a diet shift, the microbiome may be part of the story — not the whole story, and not proof that you need to “kill off” or “reseed” anything on your own.
Post-infectious IBS — a well-documented trigger
For a meaningful subset of people, IBS starts after the gut has been hit hard by an infection — the kind of “stomach bug” or foodborne illness that causes acute diarrhea, cramping, fever, or vomiting. Clinicians call this post-infectious IBS (PI-IBS). It is not a separate organ disease that shows up as visible damage on routine testing; it is IBS that begins after infectious gastroenteritis has disturbed the gut lining, immune signaling, microbiome, and gut–brain communication. NIDDK lists bacterial infections in the digestive tract among problems that may play a role in IBS, and Rome Foundation authors describe acute infectious gastroenteritis as the strongest known risk factor for developing IBS. (niddk.nih.gov)
The trigger can be bacterial, viral, or parasitic/protozoal, although bacterial gastroenteritis is especially well described. Cleveland Clinic lists examples such as E. coli, Campylobacter, Salmonella, and Shigella for bacterial PI-IBS, with norovirus and rotavirus as viral examples and Giardia-type infections as parasitic examples. The Rome Foundation report also notes that PI-IBS has been described more often after bacterial than viral infections, likely because bacterial gastroenteritis tends to cause more mucosal injury and inflammation. (my.clevelandclinic.org)
The older, non-COVID PI-IBS signal is substantial. A Rome Foundation Working Team report summarizes a systematic review of 45 studies and about 21,000 people with enteritis: pooled IBS prevalence was 10.1% at 12 months after infectious enteritis, and the relative risk of IBS was about 4.2-fold higher during the first 12 months compared with uninfected people. In plain language: after a significant gut infection, roughly 1 in 10 people may continue into an IBS pattern, especially if the infection was severe or the person already had vulnerability in the gut–brain system. (pmc.ncbi.nlm.nih.gov)
The COVID-19 pandemic sharpened this evidence because SARS-CoV-2 can involve the GI tract and because the pandemic added a second layer of stress load: fear, isolation, disrupted sleep, reduced movement, and delayed care. A 2026 review frames post-COVID IBS as part of the broader post-infection DGBI picture: (pubmed.ncbi.nlm.nih.gov)
"post-infection irritable bowel syndrome (PI-IBS), driven by SARS-CoV-2 GI tropism and pandemic stressors"
That review quantified the post-COVID signal:
"approximately 7.2% of individuals develop IBS after SARS-CoV-2 infection, with 2.6-fold higher odds vs. non-infected controls"
And it lays out exactly why “one cause” is the wrong model — the pathway is multifactorial:
"Mechanisms are multifactorial, involving ACE2-linked epithelial/neuromuscular effects, persistent low-grade inflammation, microbiota dysbiosis with reduced short-chain fatty acids, altered serotonin signaling, barrier dysfunction, and psychosocial stress acting along the gut-brain axis."
Because these are mostly observational data, they show a strong association and a well-described post-infectious pattern rather than proof that infection alone causes IBS in every case. The better model is this: an infection can push the gut into a sensitized, inflamed, microbiome-shifted state; then the nervous system keeps reading normal gut activity as threat. In a susceptible person, that can set the syndrome in motion — not because symptoms are imagined, but because the gut, immune system, microbiome, and brain–gut wiring have learned a new, more reactive baseline. A systematic review and meta-analysis found that more than 10% of people developed IBS after infectious enteritis and that risk was about 4-fold higher than in people without infectious enteritis, with higher risk linked to female sex, more severe enteritis, psychological distress, and antibiotic exposure during the infection. (pmc.ncbi.nlm.nih.gov)
Stress, the autonomic nervous system, and low HRV — the Welltory angle
Stress does not “cause IBS,” and IBS is not a sign of weakness or something imagined. A better way to think about it is this: IBS is a disorder of gut–brain interaction, meaning symptoms can come from how the gut and nervous system communicate even when routine tests do not show tissue damage. The autonomic nervous system is one of the body’s main wiring systems for that communication. It helps regulate heart rate, blood vessels, digestion, and the stress response — mostly without you deciding to do any of it. That makes it a real physiological tuning knob, not a metaphor. (niddk.nih.gov)
"Autonomic nervous system (ANS) activity is implicated in the pathogenesis of disorders of gut-brain interaction"
In IBS, this matters because the gut is not just a tube reacting to food. It has nerves, muscle patterns, immune signaling, microbial signals, and constant two-way traffic with the brain. Stress can turn up that traffic. For some people, symptoms worsen after emotional stress, after a stressful life event, or during periods when sleep, recovery, and nervous-system load are poor; for others, flares arrive without an obvious trigger. The key point is that stress is a modulator — it can precipitate, amplify, or sustain symptoms — not a character flaw and not proof that symptoms are “all in your head.” (hopkinsmedicine.org)
A systematic review with meta-analysis of wearable data in disorders of gut–brain interaction found a consistent autonomic signal: altered heart rate variability, especially patterns pointing toward reduced HRV in people with DGBI compared with healthy controls. (pmc.ncbi.nlm.nih.gov)
"reflecting HRV alterations in DGBI versus HCs"
That is the mechanistic bridge that makes IBS partly trackable. HRV reflects beat-to-beat variation in heart timing and is commonly used as a noninvasive window into autonomic regulation — especially the balance between parasympathetic “rest-and-digest” activity and sympathetic stress physiology. When your body is under load, HRV often drops. In an IBS flare, that lower HRV reading is not measuring your intestines directly; it is capturing the cardiac side of a broader autonomic state that may also be tuning gut sensitivity, motility, and pain signaling. (pmc.ncbi.nlm.nih.gov)
So the Welltory angle is not “HRV diagnoses IBS.” It does not. IBS is diagnosed from symptoms, medical history, and exclusion of red flags or other conditions when needed; there is no wearable, blood test, or imaging scan that can diagnose IBS on its own. A wearable can help you document patterns — for example, whether low recovery, poor sleep, high strain, or repeated HRV dips cluster around your flares. That pattern can be useful for self-awareness and for a more concrete conversation with a clinician. But it is a signal of autonomic strain, not a verdict on the cause of your IBS. (hopkinsmedicine.org)
Diet: a trigger, not the cause
Food gets blamed for IBS because it can be the thing you notice: you eat, then the cramping, urgency, bloating, or constipation shows up. But that timing can be misleading. In IBS, the deeper problem is usually not that one food “created” the condition; it is that the gut–brain system is easier to set off. NIDDK describes IBS as a problem of brain–gut interaction, where movement through the gut and pain signaling can be altered, and notes that food intolerances or sensitivities can cause digestive symptoms in some people — one piece of a bigger picture, not a single universal cause. (niddk.nih.gov)
The strongest dietary evidence is for the low-FODMAP diet — reducing certain fermentable carbohydrates that are poorly absorbed and can be fermented in the gut. The American College of Gastroenterology guideline recommends a limited trial of a low-FODMAP diet to improve global IBS symptoms, which is important wording: limited trial, not lifelong cure, and symptom improvement, not proof that FODMAPs caused your IBS. (pubmed.ncbi.nlm.nih.gov)
"the low FODMAP diet in IBS patients significantly reduced symptom scores on the IBS Symptom Severity Scale (IBS-SSS) (standardized mean difference (SMD) = -0.599, 5 meta-analyses, 3,761 patients)"
Read the same review's limits carefully — it doesn't fix everything, and blinding is hard. NICE specifically notes that diet trials have built-in problems such as difficulty blinding participants, and that low-FODMAP evidence needs to be interpreted in the context of support, reintroduction, and long-term uncertainty. (nice.org.uk)
"No significant effect was found on abdominal pain, stool consistency, stool frequency, or microbiota."
So the practical takeaway is not “find the one forbidden food.” It is: lower the load on a sensitized system, then learn your own thresholds. FODMAPs, large meals, fatty foods, caffeine, alcohol, and some sugar alcohols can reliably provoke symptoms for many people with IBS — by increasing gas, pulling water into the bowel, changing motility, or simply adding more stretch to a gut that is already reading normal signals as too loud. (nice.org.uk)
That is why elimination should be structured, not endless. Johns Hopkins describes low-FODMAP as a short-term, restrictive, three-step process: remove high-FODMAP foods, reintroduce them one by one, then keep only the specific limits that actually help you. The initial elimination phase is commonly described as about 2–6 weeks, while NICE notes that in NHS practice it may be used for up to 8 weeks initially; either way, the point is reintroduction and personalization, ideally with a clinician or dietitian so you do not accidentally under-eat, over-restrict, or turn food into another source of stress. (hopkinsmedicine.org)
Predisposition: genetics and early-life factors (in a subset)
IBS can run in families, but that does not mean there is one “IBS gene” or that your gut was destined to behave this way. A better way to think about it is load on the system: some people inherit or grow up with a more reactive gut–brain network, a more sensitive stress-response system, or a microbiome and immune environment that is easier to tip out of balance. Then a later trigger — an infection, prolonged stress, a dietary shift, antibiotics, hormonal changes — may be enough to cross the symptom threshold. NIDDK describes IBS as something that can arise from a combination of problems, with genes making some people more likely to develop it rather than determining the outcome. (niddk.nih.gov)
The family signal is real, but modest. In a Swedish national adoption study, adoptees were more likely to have IBS if a biological parent had IBS, while IBS in an adoptive parent was not associated with higher odds in the adoptee; the study estimated IBS heritability at 19.5% ± 8.5%. That supports a genetic contribution, but also leaves most of the risk outside genetics — in early environment, infections, stress biology, gut microbes, immune signaling, and the way all of those interact over time. (pmc.ncbi.nlm.nih.gov)
Early-life adversity is one of those non-genetic risk layers. This can include abuse, neglect, severe family stress, or other experiences that repeatedly teach the nervous system to scan for threat. In the body, that can mean a stress-response system that is quicker to activate, slower to settle, and more tightly wired into gut sensation and motility. Research in IBS links early adverse life events with altered hypothalamic–pituitary–adrenal axis responsiveness — the hormonal stress pathway that helps coordinate cortisol, arousal, inflammation, and gut signaling. (pmc.ncbi.nlm.nih.gov)
This is not a blame story. It does not mean symptoms are “psychological,” and it does not mean a difficult childhood is required for IBS. It means that, for a subset of people, early stress may tune the gut–brain axis toward higher sensitivity. A systematic review found several early-life and family factors that appeared in more than one study — including parental IBS, childhood anxiety or depression, child abuse, and some perinatal or household factors — but the evidence is mixed enough that these should be read as risk markers, not personal explanations. (pmc.ncbi.nlm.nih.gov)
So if IBS is common in your family, that history matters — it may help explain why your gut reacts more strongly than someone else’s. If you had early-life stress, that history matters too — not because the symptoms are imagined, but because the stress system and digestive system develop in conversation. And if neither applies to you, IBS can still happen. Predisposition is only the soil. It still takes triggers, mechanisms, and time for symptoms to grow.
Why IBS overlaps with fibromyalgia, ME/CFS, migraine, and appears around perimenopause
If you have IBS plus fibromyalgia, ME/CFS, migraine, or all three, it does not mean one disease is “causing” all the others. A better way to read the pattern is shared biology. These conditions often travel together because they all can involve a nervous system that has become easier to trigger, slower to settle, and more likely to amplify signals from the gut, muscles, head, or whole body. Reviews describe substantial overlap among IBS, fibromyalgia, chronic fatigue syndromes, chronic headache/migraine, and other central sensitivity conditions, while also cautioning that there is no single brain-scan “signature” that proves one identical mechanism for everyone. (pmc.ncbi.nlm.nih.gov)
In IBS, that amplification often shows up as visceral hypersensitivity: normal stretching, gas, meals, or bowel movement signals can be experienced as pain, urgency, pressure, or bloating. In migraine, a similar sensitization frame helps explain why light touch, light, sound, or ordinary sensory input can become painful during attacks or as migraine becomes more chronic. In fibromyalgia and ME/CFS, the same broad idea may show up more as widespread pain, fatigue, post-exertional crashes, sleep disruption, and orthostatic symptoms. The body part that “speaks loudest” can differ, but the volume knob is partly shared. (pubmed.ncbi.nlm.nih.gov)
The autonomic nervous system is another bridge. It helps regulate gut motility, secretion, pain signaling, heart rate, blood pressure, temperature, and the stress response. IBS studies using heart rate variability suggest altered autonomic patterns in at least a subset of patients, and ME/CFS guidance recognizes orthostatic intolerance — symptoms that worsen when upright — as a common management issue. That does not make HRV a diagnostic test for IBS. It makes autonomic load a useful body signal: when your system is under strain, your gut may become more reactive too. (pubmed.ncbi.nlm.nih.gov)
This is also why perimenopause and menopause can feel like a turning point. Falling and fluctuating sex hormones can interact with the gut–brain axis, visceral sensitivity, motility, stress-response systems, sleep, mood, and the microbiome. So the cleanest wording is not “menopause causes IBS.” It is: hormonal transition can modulate or unmask an already-sensitive gut–brain system. If your gut was barely coping before, poorer sleep, hot flashes, changing estrogen signaling, higher stress load, or migraine flares can lower the threshold enough for IBS symptoms to become more obvious. (pubmed.ncbi.nlm.nih.gov)
That is also how we interpret our own tracking data from the Welltory cohort above. The raw differences that looked “IBS-specific” largely reflected the cluster of conditions IBS travels with once we controlled for how many conditions a person has. In real life, your gut is not operating in isolation. It is sharing the same nervous-system budget with pain, fatigue, sleep, hormones, stress physiology, and autonomic regulation.
Comparison blocks (for quick extraction)
Trigger vs. cause. A trigger is the match, not the whole fire. A gut infection, a high-stress stretch, or a food your gut doesn’t tolerate well can start an IBS pattern or flare symptoms in someone who is already vulnerable. What keeps the pattern going is the mechanism underneath: your brain and gut misread each other’s signals, your bowel may contract too fast or too slowly, and ordinary gas or stool can feel painful because the gut’s sensory nerves are turned up too high. (niddk.nih.gov)
IBS vs. IBD. IBS and IBD can both give you abdominal pain, diarrhea, urgency, and a life that starts revolving around bathrooms — but they are not the same disease. IBS is a disorder of gut–brain interaction: symptoms happen without visible damage or disease in the digestive tract. IBD, which includes Crohn’s disease and ulcerative colitis, is inflammatory disease: immune activity causes chronic inflammation, ulcers, swelling, bleeding, or deeper tissue injury that clinicians can often see on tests. Overlap in symptoms is exactly why new, severe, bloody, nocturnal, feverish, or weight-loss symptoms should be checked rather than assumed to be “just IBS.” (niddk.nih.gov)
“Functional” vs. “disorder of gut–brain interaction.” These labels often point to the same family of conditions, but the newer language is kinder and more accurate. “Functional” was meant to say that routine tests may look normal; it was never supposed to mean fake, imagined, or voluntary. “Disorder of gut–brain interaction” names the biology more directly: the two-way nervous, immune, microbial, hormonal, and motility signaling between your gut and brain is not regulating smoothly. That is why symptoms can be real even when tissue looks normal. (niddk.nih.gov)
Dysbiosis association vs. causation. Microbiome changes are part of the IBS story, but they are not a single smoking gun. Studies often find that people with IBS have different gut microbial patterns than controls, and dysbiosis may plausibly feed into sensitivity, barrier function, immune signaling, gas, and motility. But the findings are inconsistent across studies and IBS subtypes, and no one accepted microbial signature has been shown to diagnose or cause IBS in humans on its own. In plain English: your microbiome may be one lever in the system, not the cause of IBS for everyone. (pmc.ncbi.nlm.nih.gov)
Who needs extra caution / when to see a clinician
IBS is usually diagnosed from your symptom pattern, medical history, exam, and limited tests used to rule out other causes — there is no single “IBS test.” That is why certain symptoms should not be folded into an IBS explanation. Get prompt medical evaluation if you have unintended weight loss, rectal bleeding, black or tarry stools, iron-deficiency anemia, fever, a family history of bowel cancer, inflammatory bowel disease, or celiac disease, or bowel symptoms that start for the first time after age 50. These signs can point to bleeding, inflammation, infection, malabsorption, or cancer risk — different biology than IBS — and they change what your clinician needs to check. (nhs.uk)
You should also be more cautious if you are pregnant, immunocompromised, or already have a bowel, thyroid, or autoimmune condition. IBS-like symptoms can overlap with celiac disease, IBD, infection, and thyroid problems; for example, overactive thyroid can cause frequent bowel movements or diarrhea, while underactive thyroid can cause constipation. In those situations, “just a flare” is not a safe assumption when symptoms are new, persistent, or clearly different from your usual pattern. (nhs.uk)
A wearable can still be useful. Bring your clinician a simple timeline: pain days, stool changes, food or stress context, sleep, cycle phase if relevant, medications or antibiotics, and HRV trends around flares. That can make the pattern easier to discuss. But a wearable cannot diagnose IBS, rule out bleeding or inflammation, or tell you the cause of your symptoms; consumer wellness tools are for tracking and organizing health information, not replacing clinical assessment. (fda.gov)
How we made it
Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article explains what is currently known about the causes of IBS. It is for educational purposes only and does not diagnose you or anyone else. New, persistent, or alarming symptoms — weight loss, bleeding, fever, or symptoms after age 50 — belong with a qualified clinician.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Symptoms & Causes of Irritable Bowel Syndrome.” https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/symptoms-causes
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Diagnosis of Irritable Bowel Syndrome.” https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/diagnosis
- Cleveland Clinic. “Disorders of Gut-Brain Interaction (DGBI).” https://my.clevelandclinic.org/health/diseases/disorders-of-gut-brain-interaction-dgbi
- Cleveland Clinic. “Irritable Bowel Syndrome (IBS): Symptoms, Causes & Treatment.” https://my.clevelandclinic.org/health/diseases/4342-irritable-bowel-syndrome-ibs
- Cleveland Clinic. “Post-Infection Irritable Bowel Syndrome.” https://my.clevelandclinic.org/health/diseases/post-infectious-ibs
- Mayo Clinic. “Irritable Bowel Syndrome — Symptoms and Causes.” https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016
- Mayo Clinic. “Irritable Bowel Syndrome — Diagnosis and Treatment.” https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/diagnosis-treatment/drc-20360064
- Johns Hopkins Medicine. “Irritable Bowel Syndrome (IBS).” https://www.hopkinsmedicine.org/health/conditions-and-diseases/irritable-bowel-syndrome-ibs
- Johns Hopkins Medicine. “FODMAP Diet: What You Need to Know.” https://www.hopkinsmedicine.org/health/expert-qa/fodmap-diet-what-you-need-to-know
- NICE. “Irritable bowel syndrome in adults: diagnosis and management — Evidence.” https://www.nice.org.uk/guidance/cg61/evidence
- NCBI Bookshelf / NICE. “Addendum to NICE guideline CG61, Irritable bowel syndrome in adults — Evidence review and recommendations.” https://www.ncbi.nlm.nih.gov/books/NBK550721/
- FDA. “Examples of Software Functions That Are NOT Medical Devices.” https://www.fda.gov/medical-devices/device-software-functions-including-mobile-medical-applications/examples-software-functions-are-not-medical-devices
- Zhang Y, Gao L, Zhang X, et al. “Application of neuromodulation techniques in irritable bowel syndrome.” Frontiers in Neuroscience (2026). PMID: 42200039; PMCID: PMC13199257; doi:10.3389/fnins.2026.1792685. https://pubmed.ncbi.nlm.nih.gov/42200039/
- “Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone.” PMCID: PMC12842271. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842271/
- “Microbial dysbiosis alters serotonin signaling in a post-inflammatory murine model of visceral pain.” PMCID: PMC12797318. https://pmc.ncbi.nlm.nih.gov/articles/PMC12797318/
- Shen H, Wang S, Zhao Y, et al. “Brain-gut-microbiota axis: a review on the bidirectional regulatory mechanisms between gut microbiota and brain and their disease interactions.” Frontiers in Microbiology (2026). doi:10.3389/fmicb.2026.1768891. https://doi.org/10.3389/fmicb.2026.1768891
- Ghoshal UC, Singh R, Goenka MK. “Post-Coronavirus Disease (COVID)-19 Irritable Bowel Syndrome: What We’ve Learned So Far.” Neurogastroenterology & Motility (2026). PMID: 41578455; doi:10.1111/nmo.70250. https://pubmed.ncbi.nlm.nih.gov/41578455/
- “Wearable-Based Monitoring of Autonomic and Gastrointestinal Function in Disorders of Gut-Brain Interaction: A Systematic Review and Meta-Analyses.” PMCID: PMC12815003; PMID: 41553708; doi:10.1111/nmo.70232. https://pmc.ncbi.nlm.nih.gov/articles/PMC12815003/
- Sadowski A, Dunlap C, Lacombe A, Hanes D. “Alterations in Heart Rate Variability Associated With Irritable Bowel Syndrome or Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.” Clinical and Translational Gastroenterology (2020). PMID: 33346998; PMCID: PMC7752679; doi:10.14309/ctg.0000000000000275. https://pubmed.ncbi.nlm.nih.gov/33346998/
- Bogdanowska-Charkiewicz D, Malinowska U, Daniluk J. “An umbrella review of meta-analyses on the low-FODMAP diet in IBS.” Frontiers in Nutrition (2026). PMID: 41550863; PMCID: PMC12807944; doi:10.3389/fnut.2025.1714281. https://pubmed.ncbi.nlm.nih.gov/41550863/
- Lacy BE, Pimentel M, Brenner DM, et al. “ACG Clinical Guideline: Management of Irritable Bowel Syndrome.” American Journal of Gastroenterology (2021). PMID: 33315591; doi:10.14309/ajg.0000000000001036. https://pubmed.ncbi.nlm.nih.gov/33315591/
- Wang L, Alammar N, Singh R, et al. “Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.” Journal of the Academy of Nutrition and Dietetics (2020). PMID: 31473156; doi:10.1016/j.jand.2019.05.015. https://pubmed.ncbi.nlm.nih.gov/31473156/
- Terry N, Margolis KG. “Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.” Handbook of Experimental Pharmacology (2017). PMID: 28035530; PMCID: PMC5526216; doi:10.1007/164_2016_103. https://pubmed.ncbi.nlm.nih.gov/28035530/
- Yano JM, Yu K, Donaldson GP, et al. “Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis.” Cell (2015). PMID: 25860609; PMCID: PMC4393509; doi:10.1016/j.cell.2015.02.047. https://pubmed.ncbi.nlm.nih.gov/25860609/
- Barbara G, Grover M, Bercik P, et al. “Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.” Gastroenterology (2019). PMID: 30009817; PMCID: PMC6309514; doi:10.1053/j.gastro.2018.07.011. https://pmc.ncbi.nlm.nih.gov/articles/PMC6309514/
- Klem F, Wadhwa A, Prokop LJ, et al. “Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis.” Gastroenterology (2017). PMCID: PMC5367939; doi:10.1053/j.gastro.2016.12.039. https://pmc.ncbi.nlm.nih.gov/articles/PMC5367939/
- Halvorson HA, Schlett CD, Riddle MS. “Postinfectious irritable bowel syndrome — a meta-analysis.” American Journal of Gastroenterology (2006). PMID: 16928253; doi:10.1111/j.1572-0241.2006.00654.x. https://pubmed.ncbi.nlm.nih.gov/16928253/
- Waehrens R, Li X, Sundquist J, Sundquist K, Zöller B. “A Swedish national adoption study of risk of irritable bowel syndrome (IBS).” PMCID: PMC5663268; PMID: 29119001. https://pmc.ncbi.nlm.nih.gov/articles/PMC5663268/
- Chitkara DK, van Tilburg MAL, Blois-Martin N, Whitehead WE. “Parental, Perinatal, and Childhood Risk Factors for Development of Irritable Bowel Syndrome: A Systematic Review.” PMCID: PMC7547188. https://pmc.ncbi.nlm.nih.gov/articles/PMC7547188/
- Zhou Q, Fillingim RB, Riley JL 3rd, Malarkey WB, Verne GN. “Central and peripheral hypersensitivity in the irritable bowel syndrome.” Pain (2010). PMID: 20074857; PMCID: PMC2913434; doi:10.1016/j.pain.2009.12.005. https://pubmed.ncbi.nlm.nih.gov/20074857/
- “Overlap between functional GI disorders and other functional syndromes.” PMCID: PMC4422459. https://pmc.ncbi.nlm.nih.gov/articles/PMC4422459/
- Heitkemper MM, Chang L. “Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?” Gender Medicine (2009). PMID: 19406367; PMCID: PMC3322543; doi:10.1016/j.genm.2009.03.004. https://pubmed.ncbi.nlm.nih.gov/19406367/
- “Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis.” PMID: 34093447. https://pubmed.ncbi.nlm.nih.gov/34093447/


-2.jpg)




